Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$309M |
| 2 |
Enbridge
ENB
|
+$233M |
| 3 |
AT&T
T
|
+$219M |
| 4 |
AGN
Allergan plc
AGN
|
+$211M |
| 5 |
MetLife
MET
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 2 |
Automatic Data Processing
ADP
|
+$694M |
| 3 |
Pembina Pipeline
PBA
|
+$382M |
| 4 |
Toronto Dominion Bank
TD
|
+$293M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.04% |
| 2 | Technology | 8.79% |
| 3 | Energy | 8.22% |
| 4 | Industrials | 7.49% |
| 5 | Communication Services | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGC
826
Canopy Growth
CGC
$426M
| $29.3M | 0.01% |
127,787
+6,745
| +6% | +$2.06M |
|
827
Sprott Physical Gold and Silver Trust
CEF
$8.17B
| $29.3M | 0.01% |
2,066,667
+223,373
| +12% | +$3.17M |
|
828
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $29.3M | 0.01% |
236,335
-52,426
| -18% | -$6.98M |
|
|
GWR
829
DELISTED
Genesee & Wyoming Inc.
GWR
| $29.2M | 0.01% |
264,526
+225,235
| +573% | +$24.8M |
|
830
Northern Trust
NTRS
$34.8B
| $29.2M | 0.01% |
312,943
-100,550
| -24% | -$9.23M |
|
831
STAG Industrial
STAG
$7.12B
| $29.2M | 0.01% |
989,381
+367,931
| +59% | +$10.9M |
|
832
Jack Henry & Associates
JKHY
$11.1B
| $29.1M | 0.01% |
199,129
+16,338
| +9% | +$2.32M |
|
833
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $29.1M | 0.01% |
924,632
+436,299
| +89% | +$13.6M |
|
834
Bankunited
BKU
$3.41B
| $29M | 0.01% |
863,768
-57,567
| -6% | -$1.88M |
|
835
PUT
Advanced Micro Devices
AMD
$789B
| $29M | 0.01% |
1,000,900
-25,000
| -2% | -$784K |
|
836
PUT
Intel
INTC
$527B
| $28.9M | 0.01% |
561,700
-375,100
| -40% | -$18.4M |
|
837
AES
AES
$10.5B
| $28.9M | 0.01% |
1,766,440
+345,499
| +24% | +$5.56M |
|
838
Bio-Techne
TECH
$11.2B
| $28.8M | 0.01% |
588,676
+95,468
| +19% | +$4.79M |
|
839
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $28.8M | 0.01% |
319,500
+100,000
| +46% | +$9.13M |
|
840
Barclays
BCS
$94.6B
| $28.8M | 0.01% |
3,920,421
+233,363
| +6% | +$1.69M |
|
841
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $28.7M | 0.01% |
1,218,305
+50,300
| +4% | +$1.17M |
|
842
PUT
Royal Bank of Canada
RY
$299B
| $28.7M | 0.01% |
+353,500
| New | +$27.6M |
|
843
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
| $28.7M | 0.01% |
430,444
+4,963
| +1% | +$325K |
|
844
ManpowerGroup
MAN
$2.75B
| $28.7M | 0.01% |
340,392
+167,743
| +97% | +$14.6M |
|
845
iShares MSCI Canada ETF
EWC
$6.55B
| $28.6M | 0.01% |
991,198
+41,674
| +4% | +$1.19M |
|
846
ITT
ITT
$19.4B
| $28.6M | 0.01% |
467,263
-16,600
| -3% | -$1M |
|
847
CALL
Pfizer
PFE
$153B
| $28.5M | 0.01% |
834,768
-789,446
| -49% | -$28.7M |
|
848
Nucor
NUE
$61.8B
| $28.5M | 0.01% |
558,873
+66,629
| +14% | +$3.48M |
|
|
SBNY
849
DELISTED
Signature Bank
SBNY
| $28.4M | 0.01% |
238,596
-141,094
| -37% | -$17.1M |
|
850
Descartes Systems
DSGX
$6.62B
| $28.4M | 0.01% |
705,194
-81,555
| -10% | -$3.02M |
|
Similar funds
Royal Bank of Canada's Q3 2019 Portfolio in Review
As of Q3 2019, Royal Bank of Canada held 7,530 positions worth $253B, up 1.6% from $249B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q3 2019 filing shows 489 new, 3,007 increased, 2,579 reduced and 641 closed positions. Its largest new stake was Genmab: 424,217 shares worth $8.6M. The largest sale was iShares Core S&P 500 ETF, an estimated $983M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Energy.
- Royal Bank of Canada's largest Q3 2019 buy was Genmab: 424,217 shares worth $8.6M.
- Royal Bank of Canada added most to Boeing in Q3 2019, an estimated $309M increase.
- Royal Bank of Canada's biggest Q3 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- Royal Bank of Canada fully exited Anadarko Petroleum in Q3 2019, selling an estimated $83.7M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $253B portfolio in Q3 2019.
- Royal Bank of Canada opened 489 new positions and closed 641 in Q3 2019.
- Royal Bank of Canada's portfolio value rose 1.6% quarter-over-quarter to $253B.
Based on Royal Bank of Canada's 13F filing for Q3 2019, filed 14 Nov 2019.